特一药业
(002728)
| 流通市值：31.66亿 | | | 总市值：43.11亿 |
| 流通股本：3.76亿 | | | 总股本：5.13亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 295,133,348.45 | 687,785,167.66 | 455,597,193.06 | 313,748,456.95 |
| 营业收入 | 295,133,348.45 | 687,785,167.66 | 455,597,193.06 | 313,748,456.95 |
| 二、营业总成本 | 258,338,480.98 | 661,960,135.48 | 461,048,868.25 | 318,750,298.51 |
| 营业成本 | 104,116,031.72 | 385,711,741.22 | 278,658,076.92 | 189,650,044.15 |
| 税金及附加 | 4,342,733 | 8,086,666.62 | 4,907,889.96 | 3,306,738.01 |
| 销售费用 | 121,926,594.34 | 151,114,865.43 | 94,632,382.96 | 70,264,094.22 |
| 管理费用 | 17,484,179.81 | 74,428,848.01 | 50,293,988.49 | 34,419,946.98 |
| 研发费用 | 9,512,915.33 | 43,334,317.79 | 33,831,090.29 | 21,656,247.54 |
| 财务费用 | 956,026.78 | -716,303.59 | -1,274,560.37 | -546,772.39 |
| 其中:利息费用 | 1,850,503.99 | 5,320,913.19 | 4,004,495.56 | 3,368,651.59 |
| 其中:利息收入 | 1,192,926.95 | 6,600,277.04 | 5,791,746.65 | 4,254,798.06 |
| 加:投资收益 | 186,410.96 | 3,735,807.58 | 1,897,393.88 | 1,046,475.74 |
| 资产处置收益 | -59,687.76 | 8,242.72 | 7,726.92 | 204.42 |
| 资产减值损失(新) | - | -12,384,839.14 | - | - |
| 信用减值损失(新) | 1,180,034.9 | 148,854.14 | 1,721,576.41 | 1,898,700.37 |
| 其他收益 | 1,766,643.58 | 6,784,354.01 | 4,666,282.2 | 3,608,471.56 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 39,868,269.15 | 24,117,451.49 | 2,841,304.22 | 1,552,010.53 |
| 加:营业外收入 | - | 44,219.8 | 7,138.08 | 1,720.29 |
| 减:营业外支出 | 451,447.66 | 2,109,304.13 | 653,670.1 | 457,403.65 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 39,416,821.49 | 22,052,367.16 | 2,194,772.2 | 1,096,327.17 |
| 减:所得税费用 | 7,849,547.84 | 1,557,363.77 | -3,815,028.12 | -1,593,103.74 |
| 六、净利润 | 31,567,273.65 | 20,495,003.39 | 6,009,800.32 | 2,689,430.91 |
| 持续经营净利润 | 31,567,273.65 | 20,495,003.39 | 6,009,800.32 | 2,689,430.91 |
| 归属于母公司股东的净利润 | 31,567,273.65 | 20,495,003.39 | 6,009,800.32 | 2,689,430.91 |
| (一)基本每股收益 | 0.06 | 0.04 | 0.01 | 0.01 |
| (二)稀释每股收益 | 0.06 | 0.04 | 0.01 | 0.01 |
| 九、综合收益总额 | 31,567,273.65 | 20,495,003.39 | 6,009,800.32 | 2,689,430.91 |
| 归属于母公司股东的综合收益总额 | 31,567,273.65 | 20,495,003.39 | 6,009,800.32 | 2,689,430.91 |
| 公告日期 | 2025-04-26 | 2025-04-26 | 2024-10-26 | 2024-07-26 |
| 审计意见(境内) | | 标准无保留意见 | | |